The review, led by Diana C. Parra of Washington University in St. Louis together with colleagues at the university’s School of Public Health and The Ohio State University, set out to answer three deceptively simple questions: What kinds of mindfulness programs are being delivered in community settings? Through what mechanisms are they thought to work? And how are researchers measuring their effects? To build the evidence map, the team searched PubMed, JSTOR, and Web of Science, screened 878 unique records after duplicate removal, and ultimately included 45 studies spanning randomized controlled trials, quasi-experimental designs, pilot and feasibility studies, longitudinal cohorts, qualitative inquiries, mixed-methods research, and conceptual analyses. The protocol was registered on the Open Science Framework, and reporting followed the PRISMA-ScR guidelines for scoping reviews. Screening was performed by two independent research assistants with adjudication by a third, achieving substantial initial agreement (Cohen’s kappa of 0.71) that improved to near-perfect consistency (kappa of 0.86) after discussion.

The geographic and demographic reach of the included studies is striking. Research teams in the United States, Canada, Spain, Australia, Denmark, Hong Kong SAR, China, Chile, Saudi Arabia, and Rwanda/Ethiopia evaluated programs delivered to university students, schoolchildren, parents and families, migrant and refugee populations, teachers, sexual minority individuals, people with severe mental health conditions, and community-dwelling older adults. The dominant intervention formats remained the classic structured programs: Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT), the eight-week curricula originally developed in clinical contexts that teach breath awareness, body scanning, mindful movement, and facilitated group reflection. Of the 45 studies, 32 delivered interventions in person, 9 used hybrid formats, and 4 were fully web-based, a distribution that reflects both the enduring appeal of group practice and the growing pull of digital delivery.

Across the synthesized literature, the psychological benefits reported were remarkably consistent in direction even when they varied in magnitude. Studies repeatedly documented reductions in perceived stress, anxiety symptoms, and depressive symptoms, alongside improvements in emotional regulation, resilience, adaptive coping, and psychological well-being. A cluster-randomized trial of school-based yoga and mindfulness in a racially diverse urban setting found significant improvements in anxiety and depression among young adolescents. An eight-week web-based mindfulness virtual community intervention produced significant reductions in depression and anxiety among university students. Among older adults, adapted MBSR programs delivered in continuing care retirement communities and a mindfulness intervention targeting sleep disturbances both yielded clinically meaningful gains. A community-based trial among hypertension patients with comorbid depression and anxiety reported not only symptom reduction but also improvements in blood pressure, one of the few studies to capture a physiological endpoint alongside psychological outcomes.

Perhaps the most provocative finding, however, concerns what mindfulness is not. In one adolescent study, a mindfulness condition performed no better than a structured wellness comparison condition in reducing anxiety, though both outperformed a waitlist control. The review’s authors flag this pattern as arguably the most consequential in the literature: in community settings, the active ingredient may be structured, supported group engagement as much as mindfulness practice itself. If the social architecture of a program, regular meetings, a trained facilitator, peer connection, accounts for much of the benefit, then funders and program designers face different decisions about how such interventions should be built, resourced, and evaluated. The finding echoes an ongoing debate about whether the specific components of mindfulness protocols drive their clinical efficacy or whether nonspecific factors such as facilitator attention and group support do much of the heavy lifting.

Mechanistic evidence remains thin but suggestive. A subset of studies examined trait mindfulness, state mindfulness, and attentional regulation as potential mediators. Increases in self-reported mindfulness skills partially accounted for improvements in mental health outcomes, and higher baseline trait mindfulness predicted stronger intervention effects. In a longitudinal path model analysis within a community-based randomized trial with six-month follow-up, changes in self-reported resting state partially mediated the effects of MBSR on mental health, which the study authors interpreted as preliminary evidence of neurocognitive processes. On the psychophysiological front, researchers measuring event-related potentials (ERPs) during meditation found that brief mindfulness interventions altered ERP components associated with more efficient cognitive processing, offering objective neural correlates of practice. Still, the review characterizes this mechanistic literature as methodologically nascent, particularly within real-world community contexts where experimental control is limited.

Cultural adaptation emerged as the review’s most cross-cutting theme, and the authors argue it functions less as a cosmetic adjustment than as a mechanism of trust and relevance that determines whether communities engage with a program at all. The included studies described programs tailored for Arabic and Bangla-speaking migrants in Australia, an eight-week online Spanish-language program for Latina immigrants called Yo soy Paz, and digital music-based mindfulness interventions grounded in Black musical traditions for Black Americans experiencing race-based anxiety. Several studies employed community-based participatory research (CBPR) approaches, involving community members in design, adaptation, and implementation from the outset. The ALMA program for Latina immigrant mothers, Amigas Latinas Motivando el Alma, demonstrated comparable acceptability across in-person and online delivery formats. Qualitative interviews with community partners confirmed that programs developed through collaborative processes were perceived as relevant, trustworthy, and effective, suggesting that cultural fit is a precondition for reach rather than an optional enhancement.

Feasibility and acceptability data were broadly encouraging: a bilingual mindfulness program for Latino adolescents and their parents, a community-derived intervention for Latinx parents and children, MBSR combined with self-compassion training for Spanish parents of children with autism spectrum disorder, and a whole-school mindfulness protocol designed for Rwanda and Ethiopia all reported strong uptake and favorable participant reception. Yet the review also surfaces a troubling silence around safety. Few studies reported adverse events, symptom deterioration, or contraindications, and none described systematic safety monitoring. The authors caution that mindfulness practice is not universally benign, transient increases in distress and, more rarely, serious adverse experiences have been documented in the broader literature, and community settings often lack the clinical oversight available in trials. The near-absence of safety reporting, they write, should be read as a gap rather than as evidence of safety.

Measurement is where the field’s fragmentation becomes most visible. Assessment was overwhelmingly self-report based, concentrated on depression, anxiety, stress, and self-rated mindfulness, frequently with heterogeneous instruments that undermine cross-study comparison. Objective indicators were rare: salivary cortisol in a trial with hospital health workers, sleep quality among older adults, ERP recordings during meditation, and blood pressure among hypertensive patients. Culturally adapted or validated instruments for non-Western populations were used infrequently, and implementation or equity outcomes were largely absent. The review also notes structural imbalances: most research originates in the Global North, many studies rely on small pilot samples, few include longitudinal follow-up or active comparison conditions, and the omission of databases such as PsycINFO and Scopus may have excluded relevant work. The authors call for rigorous evaluation designs, standardized measurement frameworks, culturally responsive implementation developed in genuine partnership with communities, routine adverse-event monitoring, and implementation science approaches that examine how community mindfulness programs are sustained and scaled. If those gaps close, they argue, community-based mindfulness could mature into a credible, scalable public health strategy for promoting mental health and resilience across diverse populations.

Subject of Research: A scoping review of mechanisms, methods, and measurement in community-based mindfulness interventions

Article Title: Exploring Mechanisms, Methods, and Measurement in Mindfulness Research: A Scoping Review of Community-Based Interventions

Article References: Parra, D. C., Regassa, A., Ataro, B., & Zhang, D. (2026). Exploring Mechanisms, Methods, and Measurement in Mindfulness Research: A Scoping Review of Community-Based Interventions. Mindfulness. https://doi.org/10.1007/s12671-026-02984-7

Image Credits: AI Generated

DOI: 10.1007/s12671-026-02984-7

Keywords: mindfulness, community-based interventions, MBSR, MBCT, mental health, scoping review, cultural adaptation, public health, stress reduction, measurement, digital delivery, health equity

The research, conducted by Susanta Sen, Asif Ali, Amit Banerjee, and Namita Chakma of the Department of Geography at The University of Burdwan in West Bengal, drew on two rounds of India’s National Family Health Survey: the fourth round, conducted in 2015–16 with 122,955 women, and the fifth round, conducted in 2019–21 with 118,700 women. The analysis focused on women aged 20 to 24 years, the standard age group used to assess child marriage prevalence under international indicators, since these women had passed beyond the age at which a legal marriage before 18 could have occurred. By comparing the two survey rounds, the researchers were able to track both the level of child marriage and the distribution of that practice across the wealth spectrum over roughly a five-year interval.

To measure inequality rigorously, the team employed the Erreygers Concentration Index, a widely used summary measure in health equity research that captures whether a health or social outcome is systematically concentrated among richer or poorer groups. A negative value of the index indicates that the outcome is concentrated among the economically disadvantaged. In both survey rounds, the Erreygers Concentration Index for child marriage was negative and statistically significant, confirming that the burden of marrying before 18 falls disproportionately on girls from poorer households. The index moved from −0.281, with a 95 percent confidence interval of −0.289 to −0.273, in the fourth round to −0.257, with a 95 percent confidence interval of −0.265 to −0.249, in the fifth round, indicating a modest narrowing of wealth-related inequality but no fundamental change in its direction or magnitude.

The absolute picture tells a similarly nuanced story. The absolute gap in child marriage prevalence between the poorest and richest groups narrowed from 20.65 percentage points in NFHS-4 to 19.04 percentage points in NFHS-5. Yet the relative measure moved in the opposite direction: the ratio of child marriage prevalence among the poor compared with the non-poor actually increased, from 2.07 to 2.20. This combination of a shrinking absolute gap and a widening relative gap is a classic pattern in epidemiology and social statistics, arising when prevalence declines faster in absolute terms among groups that already have lower baseline levels. In practical terms, even though fewer girls overall are marrying as children, a girl born into a poor household today remains substantially more exposed to the risk of early marriage than one born into affluence, and in relative terms that exposure has grown.

Beyond describing the inequality, the study’s central methodological contribution lies in its use of regression-based decomposition analysis, a technique that partitions the observed concentration index into contributions attributable to individual socio-demographic characteristics. Rather than simply noting that child marriage correlates with poverty, decomposition analysis quantifies how much of the measured inequality each factor statistically explains. The results were striking in their consistency: educational attainment dominated the explained component of wealth-related inequality in both survey rounds, accounting for 77.06 percent in NFHS-4 and 77.41 percent in NFHS-5. In other words, differences in schooling levels between rich and poor women are by far the largest statistical driver of why early marriage clusters among the disadvantaged.

The composition of the remaining explained inequality shifted over time in ways that offer clues about the changing social landscape. In the fourth survey round, place of residence, meaning the divide between urban and rural areas, was the second-largest contributor to wealth-related inequality in child marriage. By the fifth round, however, the contribution of mass media exposure had risen substantially, overtaking residential location as a key explanatory factor. This shift suggests that access to information, whether through television, radio, newspapers, or increasingly digital channels, has become a more salient axis of inequality as connectivity spreads unevenly across Indian society. It also implies that the messages, norms, and alternatives that media exposure conveys about marriage, gender roles, and women’s life courses play a measurable role in shaping when and whether girls marry.

The study also documented substantial variation across India’s states and Union Territories, underscoring that child marriage is not a uniform national phenomenon but one embedded in highly diverse regional contexts of culture, economy, and policy implementation. States differ enormously in baseline prevalence, in the steepness of the wealth gradient, and in the pace of change between the two survey rounds. This heterogeneity means that a single national policy lever, applied uniformly, is unlikely to produce equitable results. Regions where the wealth gradient is steepest may require intensively targeted approaches, while regions with lower but persistent prevalence may benefit more from broad norm-change campaigns and enforcement of existing legal prohibitions on marriage below the age of 18.

The public health significance of these findings extends well beyond the institution of marriage itself. Child marriage is internationally recognized as a driver of adverse outcomes including early pregnancy, elevated maternal and infant mortality risks, interrupted schooling, restricted economic agency, and increased vulnerability to domestic violence. When the burden of child marriage concentrates among the poorest girls, it functions as a mechanism through which poverty and disadvantage reproduce themselves across generations. The study’s conclusion that reductions in overall prevalence have not been matched by equivalent reductions in socioeconomic inequality echoes a broader theme in development research: aggregate progress can mask persistent, and sometimes widening, disparities that demand explicit equity-oriented policy attention.

The authors point toward a set of policy directions grounded in their decomposition results. Because education explains such an overwhelming share of the inequality, interventions that support girls’ secondary education, reduce the economic pressures that push families to withdraw daughters from school, and keep adolescents enrolled through the years when marriage decisions are typically made stand out as the highest-leverage options. The growing contribution of mass media exposure suggests that improving access to information, and using media channels deliberately to shift social norms around early marriage, could complement educational investments. The researchers also highlight strengthening social protection for economically disadvantaged households and explicitly prioritizing the poorest families in programmatic targeting, since the data confirm that the risk of child marriage remains most intense at the bottom of the wealth distribution.

Ultimately, the study delivers a message that is both encouraging and cautionary. India has made genuine progress: child marriage prevalence declined measurably between 2015–16 and 2019–21, and the concentration index softened slightly. But the persistence of a large absolute wealth gap, the rise in the poor-to-non-poor prevalence ratio, and the stark regional differences all indicate that the finish line remains distant for the girls whom the practice continues to touch most directly. As India and the global community pursue the elimination of child marriage under international development goals, this research argues that success should be judged not only by how far national averages fall, but by how quickly the gap closes for those at the bottom, where the consequences of marrying too young are felt most severely.

Subject of Research: Wealth-related socioeconomic inequality in child marriage among young women in India

Article Title: Wealth-related inequality in child marriage in India using decomposition analysis

Article References: Sen, S., Ali, A., Banerjee, A., & Chakma, N. (2026). Wealth-related inequality in child marriage in India using decomposition analysis. Discover Social Science and Health. https://doi.org/10.1007/s44155-026-00488-2

Image Credits: AI Generated

DOI: 10.1007/s44155-026-00488-2

Keywords: child marriage, India, wealth inequality, Erreygers Concentration Index, decomposition analysis, National Family Health Survey, girls' education, mass media exposure, social protection, public health, NFHS-5, socioeconomic disparity

The research team, led by Behrooz Karimi with colleagues Mohsen Farzin and Seyed Hamed Mirhoseini, assembled an unusually complete environmental record. Daily concentrations were tracked for seven major pollutants simultaneously: fine particulate matter known as PM2.5, coarse particulate matter or PM10, sulfur dioxide, nitrogen dioxide, nitric oxide, ground-level ozone, and carbon monoxide. These were matched against daily counts of deaths from all causes, from cardiovascular diseases, and from respiratory diseases across the city. Arak makes an ideal natural laboratory for this kind of work because its air carries a signature blend of industrial emissions, traffic exhaust, and residential fuel combustion, producing chronically elevated pollutant levels that rarely fall to levels considered safe by international standards.

Methodologically, the study relied on generalized linear models with a negative binomial distribution, a statistical framework well suited to count data such as daily death totals, which are overdispersed relative to a simple Poisson process. The models were adjusted for meteorological variables including temperature and humidity, for long-term seasonal trends, and for temporal confounders such as day of the week. Crucially, the team ran the analysis twice: once in a single-pollutant framework, where each pollutant’s association with mortality is estimated in isolation, and once in a multi-pollutant framework, where all pollutants compete for explanatory power. This dual approach matters because pollutants in real urban air are correlated with one another, sharing the same emission sources and atmospheric conditions, and single-pollutant estimates can therefore conflate the effects of a toxicant with those of the mixture it travels in.

The headline findings center on two pollutants. In the single-pollutant models, an increase in PM2.5 concentration equal to the interquartile range of its daily distribution was associated with a relative risk of 1.112 for total mortality, with a 95 percent confidence interval of 1.082 to 1.142. Sulfur dioxide performed almost identically, with a relative risk of 1.102 per interquartile range increase and a confidence interval of 1.074 to 1.131. In practical terms, a modest, routinely observed rise in either pollutant was followed within days by a measurable increase in the city’s death toll. The largest effects appeared for respiratory mortality, confirming that the lungs are the frontline of harm, although cardiovascular deaths also rose significantly with exposure.

Timing emerged as a consistent theme. The strongest mortality associations were concentrated in a lag window of zero to three days, meaning deaths rose not weeks after a pollution episode but almost immediately. This pattern is characteristic of short-term, acute effects: fine particles and acidic gases triggering arrhythmias, heart attacks, strokes, and exacerbations of asthma and chronic obstructive pulmonary disease in vulnerable people, particularly the elderly and those with pre-existing disease. Distributed lag modeling allowed the researchers to spread the effect across the days following exposure and identify precisely where the risk signal was strongest, an important refinement over simpler same-day analyses that can miss or misattribute delayed effects.

The multi-pollutant models told a subtler and arguably more policy-relevant story. When all pollutants were entered together, the associations for PM2.5 and sulfur dioxide remained statistically robust, with relative risks of 1.086 and 1.092 respectively, indicating that each exerts an independent toxic effect on mortality. Nitrogen dioxide, by contrast, saw its association attenuate substantially once co-pollutants were accounted for. The authors interpret this as evidence that nitrogen dioxide in Arak functions primarily as a marker of the traffic-related pollution mixture rather than as an independent killer. This distinction is consequential for regulators: it suggests that controlling the particulate and sulfur-containing components of the city’s air, largely tied to industrial and combustion sources, should take priority over interventions focused narrowly on the traffic-derived nitrogen oxide marker.

Seasonal stratification added another layer of insight. The mortality risk associated with PM2.5 was stronger during the summer months, a counterintuitive finding given that particulate levels in many Iranian cities peak in winter, when temperature inversions trap pollutants near the ground and residential heating burns more fuel. The researchers propose that enhanced photochemical activity in summer transforms and reactivates particle-bound components, generating secondary pollutants and more chemically aggressive aerosols. Sunlight-driven atmospheric chemistry can oxidize sulfur and nitrogen compounds into sulfates and nitrates, alter the oxidative potential of particles, and interact with elevated ozone, all of which may amplify the biological toxicity of a given mass concentration of particulate matter. For health impact assessments, this implies that mass-based metrics alone may understate summer risk.

Translating the statistical associations into a burden estimate, the team calculated that 527 deaths per year in Arak, or 5.0 percent of total mortality, are attributable to ambient air pollution exposure. Respiratory mortality showed the highest vulnerability, a pattern consistent with the toxicology of inhaled particles and sulfur gases, which deposit in the airways and provoke inflammation, oxidative stress, and impaired host defense. The biological plausibility is well supported by the broader literature: fine particles have been shown to cause endothelial injury and systemic inflammation, and sulfur dioxide exposure has repeatedly been linked to cardiovascular hospitalizations in European multi-city studies. What the Arak study adds is a quantified, locally grounded estimate for a rapidly industrializing Middle Eastern city, a category of urban environment that global burden-of-disease calculations have historically struggled to represent.

The findings also fit into a widening body of evidence on air pollution in Iran. Previous systematic reviews and meta-analyses had already established associations between air pollution and cardiovascular and respiratory mortality and hospitalizations across Iranian cities, and land-use regression modeling in Arak itself had documented pronounced spatial variation in particulate concentrations tied to industrial activity. Earlier work in Isfahan had quantified the health and economic costs of fine particulate matter there. Yet the new study is notable for its duration, its breadth of pollutants, and its explicit comparison of single- and multi-pollutant frameworks, which together allow the authors to make a prioritization argument that single-pollutant studies cannot: emission control strategies should target particulate matter and sulfur-containing pollutants first, because these are the components whose independent toxicity survives rigorous statistical scrutiny.

For a city of Arak’s size, 527 excess deaths a year is not an abstraction. It is a continuous, largely invisible toll, equivalent to a preventable public health emergency unfolding one day at a time, with risk peaking within seventy-two hours of each pollution episode. The study’s authors frame the burden as substantial and, critically, preventable, pointing to emission control as the decisive lever. In low- and middle-income countries, where industrial growth often outpaces environmental regulation, the Arak experience offers both a warning and a template. Ten years of routine monitoring data, rigorously analyzed, can identify which pollutants kill, on what timescale, and in which seasons, giving policymakers the evidence needed to justify interventions, from industrial scrubbers and fuel sulfur limits to traffic management, that could remove a five percent surcharge from the city’s annual death count. Whether that happens, the authors suggest, is now less a scientific question than a political one.

Subject of Research: Short-term effects of ambient air pollution on cause-specific mortality in an Iranian industrial city over ten years

Article Title: Mortality burden of air pollution in an Iranian industrial city: a 10-year multi-pollutant time-series study

Article References: Karimi, B., Farzin, M., & Mirhoseini, S. H. (2026). Mortality burden of air pollution in an Iranian industrial city: a 10-year multi-pollutant time-series study. Air Quality, Atmosphere & Health, 19(9), Article 207. https://doi.org/10.1007/s11869-026-02098-y

Image Credits: AI Generated

DOI: 10.1007/s11869-026-02098-y

Keywords: air pollution, PM2.5, sulfur dioxide, mortality, time-series analysis, Iran, industrial city, cardiovascular mortality, respiratory mortality, multi-pollutant models, public health, attributable risk

The review, conducted by Mahlodi Esther Masekela, systematically mapped the literature on BTEX emissions from household firewood combustion published between 1994 and 2025, following the Arksey and O’Malley scoping framework and adhering to PRISMA-ScR reporting guidelines. Searches across ScienceDirect, Web of Science, Google Scholar, and Scopus identified 583 records, which were screened down to just five eligible peer-reviewed studies. That tiny number is itself a striking finding: after three decades of research, only a handful of investigations have quantitatively characterized BTEX emissions from the specific firewood species burned in domestic cookstoves, and the review’s central concern is what those few studies leave out.

The core methodological problem is the mismatch between study design and real-world fuel use. Four of the five included studies—80 percent—examined only single firewood species, burning one taxonomically distinct wood type at a time. But households in low- and middle-income countries rarely do this. Research in South Africa has documented that families typically use bundles containing up to six different tree species, while studies in Ethiopia have found that mixed fuels, principally wood combined with animal dung, are the most common cooking fuels. Laboratory work has shown that blending fuels fundamentally alters both the total volatile organic compound concentrations and the relative proportions of individual compounds, meaning single-species emission profiles may simply not represent what happens in a real kitchen.

Geography compounds the problem. Four of the five studies were conducted in high-income countries, mostly in Europe—Portugal, Sweden, and Finland—plus one in the United States, while only a single study, from South Africa, represents the low- and middle-income country context. This distribution is starkly inverted relative to the disease burden: firewood accounts for roughly 25 to 60 percent of energy consumption in middle-income countries and up to 60 to 95 percent in developing contexts, while high-income countries derive less than 5 percent of their energy from wood, largely burning it in modern stoves designed to minimize emissions. All five studies were conducted in countries with less than 10 percent primary reliance on polluting fuels and cookstoves, meaning the existing evidence comes almost exclusively from low-exposure settings while the populations facing the highest exposures in Africa and Asia remain critically under-represented. Africa’s air quality monitoring density—just 0.03 monitors per million inhabitants—leaves BTEX emission factors and source profiles largely absent precisely where they are most urgently needed.

Setting matters just as much as species. Most of the reviewed studies were conducted in purpose-built laboratory combustion facilities, and none achieved a full rating for real-world setting representativeness in the review’s quality appraisal. The only study that approached household realism, the South African investigation in Senwabarwana, used a simulated kitchen structure and still could not capture the full variability of actual kitchen geometry, ventilation, and occupant behavior. This matters because field studies of other products of incomplete combustion have repeatedly shown that real-world emissions exceed laboratory measurements and display far greater variability, reflecting inconsistent stove operation, fluctuating fuel quality, and diverse user behaviors that controlled experiments systematically exclude. When laboratory data are used for population-level exposure assessment without field validation, the review warns, health burden estimates risk being systematically biased.

The synthesis also revealed a consistent chemical hierarchy that cuts across geography and methodology. Benzene was the most consistently reported and highest-emitting BTEX compound in every study, with emission profiles generally following the pattern benzene, then toluene, then ethylbenzene, then xylenes. Among studies reporting comparable emission factors in milligrams per kilogram, benzene values ranged from 108 mg/kg for European beech to 1,500 mg/kg for birch logs—a 13.9-fold difference across single-species combustion alone, though the review cautions that differences in adsorbent chemistry between the studies’ sampling methods may account for some of this spread. Benzene’s dominance echoes broader literature on residential wood combustion and suggests it may be a fundamental feature of firewood combustion chemistry rather than a species-specific artifact, arising from the thermal degradation of lignin, the principal aromatic precursor in wood. Still, with only two studies providing complete four-compound profiles, the review frames this pattern as preliminary rather than definitive.

Reporting practices added further obstacles to comparison. Only two of the five studies reported a complete BTEX profile; three omitted ethylbenzene entirely, and one reported benzene only. Ethylbenzene, a Group 2B possible carcinogen that is relatively more abundant in biomass-burning profiles and can help distinguish those emissions, was systematically absent from 60 percent of the studies, potentially due to co-elution with xylene isomers and intermittent detection. The studies also used incompatible metrics: four reported emission factors, which characterize fuel or stove performance, while others reported ambient concentrations relevant to health risk assessment. These quantities are not interchangeable, and the review argues that both are needed simultaneously to serve source characterization and exposure assessment alike. Analytical approaches further fragmented the evidence, spanning adsorbent-based gas chromatography, whole-air canister sampling, and Fourier-transform infrared spectroscopy, each with distinct trade-offs in detection limits, sample stability, and susceptibility to interference.

The health stakes are considerable. Households in low- and middle-income countries typically cook three times a day, four to six hours per session—roughly 21 meals per week, far above the global average—implying chronic exposure far exceeding the 365-day threshold used in toxicology. Benzene targets the hematopoietic system, with prolonged exposure linked to aplastic anemia and leukemia, while toluene is associated with cognitive impairment and cardiac sensitization, and xylenes with headaches and memory deficits. Simultaneous co-exposure complicates matters further: BTEX compounds compete for shared metabolic pathways involving the enzyme CYP2E1, producing less-than-additive metabolism but potentially greater-than-additive neurological effects as unmetabolized parent compounds persist in the bloodstream. With benzene concentrations measured at combustion sources running thousands of times above the World Health Organization’s most stringent risk-based reference level, and BTEX vapors persisting indoors for one to fourteen days, poorly ventilated kitchens may never fully clear between cooking episodes.

The review concludes that the effect of mixed-species combustion on BTEX emissions remains an unresolved gap in the literature, and it calls for future studies designed around the mixed fuel bundles and fuel stacking practices—wood co-burned with coal, charcoal, crop residues, and dung—that actually characterize household energy use in low- and middle-income settings, conducted within real homes rather than laboratories. Standardized full-profile BTEX reporting, integration of combustion frequency and ventilation data, and field-based exposure measurements are identified as priorities. Until the evidence base aligns with the conditions under which exposure actually occurs, the review warns, the populations bearing the greatest burden from firewood smoke will remain the least represented in the science meant to protect them.

Subject of Research: Methodological gaps in BTEX emission studies from household firewood combustion and their implications for indoor air pollution exposure assessment.

Article Title: Methodological Gaps in BTEX Emission Studies from Household Firewood Combustion: Implications for Exposure Assessment and Indoor Air Pollution

Article References: Masekela, M. E. (2026). Methodological Gaps in BTEX Emission Studies from Household Firewood Combustion: Implications for Exposure Assessment and Indoor Air Pollution. Environmental Challenges, Article 101665. https://doi.org/10.1016/j.envc.2026.101665

Image Credits: AI Generated

DOI: 10.1016/j.envc.2026.101665

Keywords: BTEX, benzene, firewood combustion, indoor air pollution, household energy, exposure assessment, scoping review, LMICs, volatile organic compounds, clean cooking, wood smoke, public health

The research team, led by Justin Berk of Alpert Medical School at Brown University and the Center for Health and Justice Transformation, focused on a system that has become a national reference point. The Rhode Island Department of Corrections is a unified state system housing both pretrial and sentenced individuals, and it has operated one of the longest-running medications for opioid use disorder programs in the United States, in place since 2016. That longevity made it an ideal setting to ask a question that clinical trials rarely capture: what does medication-assisted treatment actually do to the daily workings of a correctional institution over years of implementation?

Methodologically, the study relied on semi-structured qualitative interviews with nineteen incarcerated individuals and ten correctional and medical facility staff. The interviews explored the cultural and operational context of medication implementation, including experiences with extended-release injectable buprenorphine, a long-acting formulation administered monthly that has become increasingly important in correctional settings. All interviews were audio-recorded and transcribed, and the researchers analyzed them using applied thematic analysis, a systematic qualitative method that identifies recurring patterns of meaning across participant accounts. The study received approval from the Brown University Health Institutional Review Board and the Rhode Island Department of Corrections Medical Research Advisory Group, and all participants provided written informed consent.

Three major themes emerged from the analysis, and the first concerns what researchers call facility climate. Participants perceived that the availability of opioid use disorder medications reduced contraband drug use, violence, and disciplinary infractions within the facilities. This is a significant finding because contraband opioids, particularly illicit fentanyl, have become a central security and public health threat in jails across the country. When incarcerated people can obtain evidence-based treatment that relieves cravings and prevents withdrawal, the black-market demand that drives smuggling, debt, and violence may shrink. Interviewees also described improvements in social functioning, including greater participation in court proceedings and rehabilitative programming, suggesting that stabilized patients engage more constructively with the legal and institutional processes they must navigate.

The second theme directly addresses the objection most often raised by skeptics of prison-based addiction treatment: diversion, the practice of saving or trading medication doses for other purposes. Diversion did occur in the Rhode Island system, participants reported, often to get high or to manage withdrawal symptoms. But interviewees perceived it as limited in scope, and most patients were perceived to use their medications as prescribed. Importantly, participants emphasized that diversion is not unique to opioid treatment medications; it also occurs with other prescribed drugs in correctional settings. From a security-management perspective, this reframes diversion from a disqualifying danger into a routine, manageable clinical and operational problem comparable to those already handled with other medications every day.

Extended-release injectable buprenorphine emerged as a particularly effective tool in this regard. Because the medication is a monthly depot injection administered under clinical supervision rather than a daily tablet that passes through many hands, it was widely regarded by participants as a strategy that reduces both diversion risk and operational burden. Daily observed dosing of medication is labor-intensive for medical staff and creates choke points that custody staff must manage; a monthly injection collapses that logistical challenge. For administrators weighing the costs of running a medication program, the injectable formulation appears to offer a practical compromise that preserves clinical benefit while addressing the security concerns that most commonly stall implementation.

The third theme is the most culturally revealing: even in a system with nearly a decade of continuous program operation, stigma toward these medications persisted among some custody staff and some incarcerated peers. Skepticism about whether opioid agonist treatment constitutes real recovery, or whether it merely substitutes one drug for another, remains a durable cultural artifact within corrections. The study identifies education and leadership support as the critical levers for overcoming this resistance. Programs that invested in training and in visible, sustained buy-in from leadership were better positioned to convert skeptics and to integrate addiction treatment into the institutional identity rather than treating it as an exception or an imposition.

Notably, the researchers found that medication implementation created opportunities for improved collaboration between medical and security staff, even though some tensions remained. In many facilities, healthcare units and custody operations function as parallel hierarchies with different priorities: one oriented toward health, the other toward order. A shared program like medications for opioid use disorder forces the two sides into regular coordination, from dosing logistics to responding to diversion incidents, and participants described how this contact could build mutual understanding. The tensions that persisted did not disappear, but the study suggests the medication program itself can serve as a structure through which interdisciplinary working relationships develop.

The implications extend well beyond Rhode Island. Most jails and prisons in the United States still do not offer all three FDA-approved medications for opioid use disorder, and diversion fears remain the most commonly cited barrier. People leaving incarceration face a dramatically elevated risk of fatal overdose in the days and weeks after release, a phenomenon documented repeatedly in the public health literature, because tolerance lost during abstinence meets unchanged patterns of use. Treatment that begins inside and continues after release is among the strongest known protective factors. If implementing such treatment also reduces violence and disciplinary problems inside, as this study’s participants perceived, then the institutional case for medication programs becomes considerably harder to dismiss on purely administrative grounds.

The authors caution, appropriately, that these are perceptions gathered from a single state system with an unusually mature program, and qualitative findings describe lived experience rather than measuring outcomes directly. But the study’s conclusions are clear and actionable: medications for opioid use disorder in correctional settings can support a safer, more stable facility environment, diversion concerns appear manageable and comparable to those of other medications, and programs that invest in education, leadership engagement, and medical-security partnerships are best positioned to overcome resistance. For a nation whose jails have become de facto frontline institutions of the overdose crisis, the Rhode Island experience suggests that the contraband-versus-medicine debate may finally be resolving in favor of medicine, and that the benefits flow to security officers, medical staff, incarcerated people, and the communities they return to alike.

Subject of Research: Qualitative study of how medications for opioid use disorder reshape culture, operations, and safety in correctional facilities

Article Title: From contraband to collaboration: a qualitative study of how medications for opioid use disorder can reshape correctional culture and safety

Article References: Berk, J., Martin, M., Cook, M., Miller, C., Suh, M., Murphy, C., Jack, H. E., Rich, J. D., Brinkley-Rubinstein, L., & Guthrie, K. M. (2026). From contraband to collaboration: a qualitative study of how medications for opioid use disorder can reshape correctional culture and safety. BMC Public Health. https://doi.org/10.1186/s12889-026-29554-9

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29554-9

Keywords: opioid use disorder, medications for opioid use disorder, buprenorphine, correctional health, jails and prisons, diversion, harm reduction, implementation science, qualitative research, overdose prevention, correctional culture, public health

The survey, the 30th wave of a nationally representative panel study, was conducted Aug. 4-17, 2026, among 1,904 empaneled U.S. adults by SSRS, an independent research company, using both web and telephone interviews. The margin of sampling error for the full sample is plus or minus 3.2 percentage points at the 95 percent confidence level, and the data were weighted to reflect the U.S. adult population. Sixty-five percent of respondents said climate change is increasing the risk of heat-related illnesses, respiratory diseases, and insect-borne diseases. That figure is unchanged from August 2025, when it also stood at 65 percent, and from July 2024, when it reached 67 percent, but it is significantly higher than the 58 percent recorded in November 2023. The trajectory suggests a durable shift in public perception rather than a temporary spike tied to any single weather event.

Americans also broadly recognize that heat waves themselves are intensifying. Sixty-two percent say U.S. heat waves are becoming more frequent and more intense than in the past, statistically unchanged from 61 percent in August 2025, 65 percent in July 2024, and 58 percent in November 2023. The survey measured four categories of extreme weather and their effects on daily routines. Extreme outdoor heat topped the list, with 76 percent of respondents reporting that it affected their daily activities at least sometimes over the past year. Poor air quality resulting from wildfire smoke came next at 38 percent, while flooding (20 percent) and tornadoes or hurricanes (11 percent) were cited far less often, consistent with their lower frequency. Notably, the more frequently respondents reported that extreme heat, poor air quality, or flooding had disrupted their daily activities, the more likely they were to believe that climate change is raising the risk of heat-related, respiratory, and insect-borne illnesses.

The financial toll of extreme weather is also registering in household budgets. Nearly half of Americans, 46 percent, say that during the past year they faced unexpected utility expenses caused by storms, flooding, heat, or wildfires, statistically unchanged from 45 percent in August 2025. Thirteen percent reported unexpected homeowner’s insurance premium expenses from these causes, a significant decline from 18 percent a year earlier, while 8 percent reported unexpected health care expenses, unchanged from August 2025. Ken Winneg, APPC’s managing director of survey research, said the pattern reflects a broader transformation in how extreme heat fits into everyday life. “Extreme heat is no longer just an occasional inconvenience,” Winneg said. “It is affecting Americans’ household budgets and daily routines, from electricity bills to simply going outside.”

When asked specifically about the impact of extreme heat on their activities and lifestyle over the past year, majorities reported at least a minor effect across several domains. Eighty-two percent said extreme heat had a major or minor impact on their electricity bills, 75 percent on outdoor activities, 56 percent on exercise routines, and 56 percent on sleep. Several of these measures have climbed since August 2025: the share reporting a major or minor impact on exercise and sleep rose to 56 percent from 50 percent, and the proportion reporting effects on pets increased to 45 percent from 37 percent, all statistically significant increases. The data paint a picture of heat as a persistent, ambient stressor that shapes decisions about when to exercise, how well people sleep, and even how families care for their animals, rather than a rare emergency confined to the hottest afternoons of the season.

Despite this widespread exposure, public awareness of protective resources remains strikingly low. Sixty-five percent of Americans say they do not know the location of a cooling center they could go to in the event of extreme heat, while just 35 percent say they know where one is located. That knowledge level has shown little recent movement: 35 percent knew a cooling center location in August 2025 and 33 percent in July 2024, although the current figure is significantly higher than the 30 percent recorded in November 2023. Laura A. Gibson, an APPC research analyst, argued that the gap represents a communication failure that communities can address. “As we continue to experience extreme heat,” Gibson said, “communities need to do more to make the public, particularly vulnerable populations, aware of these cooling facilities.”

Unhealthy air quality, which is closely related to extreme heat through wildfire activity, has also become a more visible problem. During the summer of 2026, much of the nation experienced smoky and hazy conditions from wildfires. Six in 10 Americans, 60 percent, say the area where they live experienced days in the past three months when local health authorities reported that the air quality was unhealthy, up significantly from 48 percent in August 2025. Another 24 percent said their area did not experience such days, and 16 percent were unsure. The American Lung Association’s “State of the Air” 2026 report found that 44 percent of Americans live in areas earning failing grades for unhealthy levels of ozone or particle pollution, providing an independent corroboration of the public’s reported experience.

People who reported unhealthy air in their area took a variety of protective measures, several of which have become more common over time. Eighty-two percent said they responded to local authorities’ air-quality warnings by staying indoors more than they typically would, up from 76 percent in August 2025 and 74 percent in August 2023. Fifty-one percent closed their windows, compared with 45 percent in August 2025 and 48 percent in August 2023. Forty-eight percent turned on the air conditioning, statistically unchanged from 47 percent in August 2025 but significantly higher than 37 percent in August 2023. Twenty-two percent used a room-air purifier, compared with 19 percent in August 2025 and 17 percent in August 2023, and 12 percent wore a KN95 or N95 mask outdoors, up significantly from 7 percent in August 2025 and statistically similar to 9 percent in August 2023.

Looking ahead, a majority of Americans expect the dangers of extreme heat to intensify. Nearly six in 10, 59 percent, say people in their community will be more likely to experience heat stroke caused by extreme heat waves in the next 10 years. Twenty-nine percent said people will be about as likely to experience it, 4 percent said less likely, and 8 percent were unsure. That expectation is essentially unchanged from August 2025, when 59 percent anticipated greater risk, and July 2024, when 58 percent did, but it remains significantly higher than the 52 percent recorded in November 2023. The consistency of this outlook across three annual survey waves indicates that anticipation of worsening heat risk has become a settled feature of public opinion rather than a reaction to any single summer.

Knowledge of the specific symptoms of heat-related illness, however, remains uneven, and the survey identified notable gaps in health literacy. In August 2026, 88 percent of Americans correctly identified dizziness as a sign of heat-related illness, 83 percent identified nausea, and 72 percent identified hot, red, dry, or damp skin. But only 47 percent identified cold, pale, and clammy skin as a symptom, even though that presentation is a recognized warning sign. Just 5 percent incorrectly identified hunger as a symptom. “Most Americans recognize that climate change is increasing the risk of heat-related and other illnesses, but our findings show that recognizing the risk doesn’t always translate into knowing the signs of heat-related illness,” Winneg said. “That knowledge can be especially important as extreme heat becomes an increasingly common part of Americans’ lives.”

Two further knowledge gaps stand out in the data. Only 32 percent of Americans know that pregnant people exposed to extreme heat are more likely to deliver their babies early than pregnant people who are not exposed. Nearly half, 49 percent, said they were not sure, 17 percent incorrectly said exposed pregnant people are just as likely to deliver early, and 3 percent said they are less likely to do so. That level of knowledge has not changed significantly from August 2025, when 33 percent knew the fact, or July 2024, when 30 percent did, although it is significantly higher than the 24 percent recorded in November 2023. Meanwhile, most Americans do correctly identify who is most vulnerable to fatal heat: 69 percent said heat-related deaths are most common among adults ages 65 and older, while 8 percent said children, 2 percent said adults ages 21 to 40, and 4 percent said adults ages 41 to 64, with 16 percent unsure. That figure is unchanged from August 2025 but significantly higher than the 62 percent recorded in August 2022.

Taken together, the survey results suggest a public that has absorbed the reality of a hotter, smokier, more disruptive climate into its everyday routines and expectations, even as critical gaps persist in knowledge about protective resources and medical warning signs. The APPC’s Annenberg Science and Public Health survey panel has been tracking American public knowledge, beliefs, and behaviors regarding vaccination, Covid-19, flu, RSV, climate, and other consequential health issues, providing one of the longest-running longitudinal windows into how health perceptions evolve alongside environmental change. In addition to Gibson and Winneg, the ASAPH survey team includes Patrick E. Jamieson, director of the Annenberg Health and Risk Communication Institute, which oversees the survey; research analyst Shawn Patterson Jr.; and Kathleen Hall Jamieson, APPC’s director emerita. As records continue to fall and heat becomes a structural feature of American life, the survey’s authors suggest, closing the gap between risk awareness and practical preparedness will be one of the most consequential public health communication challenges of the coming decade.

Subject of Research: Public perceptions of climate change's health effects during the hottest U.S. summer on record

Article Title: In hottest summer on record, 2 in 3 Americans say climate change is increasing heat-related illnesses

Article References: In hottest summer on record, 2 in 3 Americans say climate change is increasing heat-related illnesses. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: extreme heat, climate change, heat-related illness, Annenberg Public Policy Center, ASAPH survey, air quality, wildfire smoke, cooling centers, heat stroke, public health, NOAA, household costs

The study, published in Public Health in Practice, was conducted through a cross-sectional online survey administered between April and June 2021. Experts from healthcare, academic and governmental institutions, and patient associations were recruited through a purposive, network-based sampling strategy in which national ENABLE representatives identified colleagues with clinical, policy, or research expertise in adherence. The survey was piloted among 12 experts from five countries before deployment, and open-ended responses were analyzed using the qualitative framework method, in which pairs of researchers independently coded each response before reconciling their decisions through team consensus. The resulting codes were then quantified at the respondent level and compared across Western, Central, and Eastern European regions defined by the Global Burden of Disease classification.

The professional landscape of adherence support proved to be dominated by three groups. Physicians, including general practitioners, specialists, and clinical pharmacologists, were named by 90.7 percent of respondents as being involved in medication adherence management in their country. Pharmacists followed at 70.7 percent, and nurses at 55.7 percent. Beyond this core trio, involvement dropped sharply: other professionals such as medical technicians, physiotherapists, midwives, and social services were cited by just 10 percent, psychologists by 7.1 percent, and national health insurance institutes by 5 percent. Regional patterns varied, with nurses far more likely to be cited in Western Europe, where 72.1 percent of respondents mentioned them, compared with 41.3 percent in Central Europe, suggesting that the structure of national health systems shapes who takes responsibility for keeping patients on treatment.

When experts described what happens once a patient is identified as non-adherent, communication and education emerged as the most frequently reported intervention category in every region, cited by 83.6 percent of Western, 87.3 percent of Central, and 68.8 percent of Eastern European respondents. This category encompassed direct patient communication, patient education, peer support groups, self-care training programs, shared decision-making, motivational interviewing, and longer consultations. Follow-up and monitoring was the second most common category, reported by 60.7 percent of Western, 49.2 percent of Central, and 43.8 percent of Eastern European experts, and included closer follow-up visits, regimen simplification, dose-dispensing by pharmacies, and structured medication reviews.

The two remaining categories revealed a more fragmented picture. Collaborative and multidisciplinary approaches, such as involving other healthcare professionals, home care staff, or family caregivers, and technological solutions, including mobile apps, reminders, and pill organizers, were reported significantly less often by Central and Eastern European respondents than by their Western counterparts. Exploratory statistical testing using the Fisher–Freeman–Halton exact test, with p-values adjusted by the Benjamini–Hochberg procedure, found regional differences for both categories, each with an adjusted p-value of 0.046 and a Cramér’s V of roughly 0.24, indicating a modest but measurable association between region and intervention type. Western Europe’s more frequent use of collaborative models may reflect better-resourced systems, but the authors caution that professional boundaries and time constraints can limit multidisciplinary working even where infrastructure exists.

Perhaps the most consequential finding concerns which interventions experts actually believe work. Direct patient communication, encompassing motivational interviewing, shared decision-making, longer consultations, peer support, and patient training, was the single intervention most frequently perceived as successful, identified by 35 percent of all respondents. At the category level, communication and education again led in every region, cited as successful by 36.1 percent of Western, 46.0 percent of Central, and 50 percent of Eastern European experts. Collaborative approaches were seen as successful by 34.4 percent of Western respondents but only 20.6 percent of Central and 6.3 percent of Eastern respondents, while follow-up and monitoring was named by 19.7, 23.8, and 6.3 percent respectively. Notably, after adjustment for multiple comparisons, none of these regional differences in perceived success reached statistical significance, leaving the descriptive patterns suggestive rather than definitive.

The gap between availability and perceived effectiveness is itself revealing. Roughly eight in ten experts said direct patient communication was available in their country, yet only slightly more than a third judged it successful. The authors point out that communication is not inherently beneficial: a clinician who blames or reprimands a patient for missing doses is also communicating directly, and likely counterproductively, since patients who feel judged may disengage further. Limited consultation time, heavy workloads, variable communication skills, health literacy gaps, language barriers, and the compounding complexity of multimorbidity and polypharmacy all constrain how well conversations about medicines can translate into sustained behavior change. The finding echoes a broader evidence base showing that physician communication quality is one of the strongest modifiable predictors of adherence.

Technology, often heralded as the future of adherence support, played a surprisingly marginal role. Fewer than a third of experts reported technological solutions as available, and they were perceived as successful even less often. The authors attribute this limited uptake to practical barriers documented in prior research: uncertain reimbursement, poor integration with electronic health records and pharmacy systems, data privacy concerns, and uneven digital literacy and access among older or multimorbid patients, precisely the populations most likely to need adherence support. This aligns with systematic reviews that have found digital adherence tools to be only moderately effective on average, suggesting that apps and reminders are best understood as complements to, rather than substitutes for, human interaction.

The COVID-19 pandemic provided an unplanned stress test of how adherence support adapts under disruption, and the results were sobering. Some 40.7 percent of experts reported no specific medication adherence initiatives in their countries during the pandemic, although the authors urge caution since responses were retrospective and depended on respondents’ awareness of national or local programs. Among the adaptations that were reported, telemedicine, including e-prescriptions, led at 15.7 percent, followed by easier access to medicines through pharmacist services and home delivery at 7.9 percent, and informative campaigns, lectures, and webinars at 6.4 percent. Respondents from Central Europe described the widest range of initiatives, including vaccination-related actions and educational programs for healthcare professionals. The heterogeneity underscores, the authors argue, the need to build resilient and accessible adherence support that can withstand major healthcare disruptions rather than being improvised mid-crisis.

The study’s implications reach beyond academic classification. Because the analysis maps what is actually practiced rather than what trials recommend, it identifies concrete candidates for future implementation research: structured adherence checks embedded in routine visits, documentation in electronic records, monitored adherence indicators, and multidisciplinary teams that combine communication, behavioral, digital, and system-level approaches. The authors are candid about limitations, including possible selection bias from network-based recruitment, an Eastern European subsample of only 16 respondents from four countries, reliance on expert perception rather than objective effectiveness data, and the absence of probing possible in a self-administered survey. Yet the scale of the exercise, spanning 35 countries and coordinated through the COST Action ENABLE network, makes it an unusually comprehensive snapshot. Its central message is likely to resonate with clinicians and policymakers alike: before Europe invests in the next generation of adherence technology, it should first ensure that the oldest intervention, a trusted conversation between patient and professional, is done well, consistently, and everywhere.

Subject of Research: Expert-reported mapping of medication adherence interventions across 35 European countries

Article Title: Mapping medication adherence interventions across Europe: Expert perspectives from 35 countries

Article References: Mucherino, S., Aarnio, E., Qvarnström, M., Hafez, G., Kamusheva, M., Potočnjak, I., Trečiokiene, I., Mihajlović, J., Ekenberg, M., van Boven, J., & Leiva-Fernandez, F. (2026). Mapping medication adherence interventions across Europe: Expert perspectives from 35 countries. Public Health in Practice, 12, Article 100850. https://doi.org/10.1016/j.puhip.2026.100850

Image Credits: AI Generated

DOI: 10.1016/j.puhip.2026.100850

Keywords: medication adherence, Europe, ENABLE, patient communication, healthcare professionals, technological solutions, multidisciplinary care, COVID-19, survey research, public health, pharmacists, health systems

Most previous research on the connection between PM2.5 — airborne particles smaller than 2.5 micrometers that can penetrate deep into the lungs — and influenza has focused on short delays measured in days. Those studies have generally found that elevated pollution coincides with, or slightly precedes, increased influenza activity. But the possibility that severe episodes could exert an influence over a timescale of weeks has remained largely untested, largely because it requires long, continuous surveillance records and statistical machinery capable of examining a whole range of lag intervals simultaneously. The new research set out to fill that gap using an unusually rich national dataset.

The research team, led by atmospheric scientists and environmental health specialists from Yonsei University, Jeju National University and the National Institute of Environmental Research, assembled weekly PM2.5 observations from South Korea’s nationwide monitoring network alongside laboratory-confirmed influenza surveillance data spanning 2015 through 2025. To avoid the distortions introduced by the COVID-19 pandemic, which dramatically suppressed influenza transmission through nonpharmaceutical interventions, the years 2020 to 2022 were excluded from the analysis. The investigators then converted the raw concentrations into anomalies calculated by epidemiological week, a statistical maneuver that isolates how much each week’s pollution and influenza activity deviated from typical levels for that point in the season, stripping away the strong seasonal cycles that could otherwise masquerade as associations.

Two complementary modeling approaches anchored the analysis. The first was a repeated single-lag model, which estimates the association between a pollution anomaly in one week and an influenza anomaly a fixed number of weeks later, repeating the calculation across a sequence of lag times. The second was a constrained distributed lag model, which fits the shape of the lagged effect across multiple weeks at once while limiting how wildly the estimated effect can swing from one lag to the next. Together, the two frameworks provide a check on one another: a genuine delayed signal should appear consistently in both, whereas statistical noise typically produces estimates that lurch unpredictably across the lag dimension.

When the models were run across all weeks of the year, no robust lagged association between PM2.5 and influenza emerged. The picture changed, however, when the analysis was restricted to epidemiological weeks 8 through 20 — roughly late February through mid-May, the tail of the Korean influenza season and the height of the spring haze season. In that window, the estimated associations rose steadily as the lag increased, peaking at lags of five and six weeks in both models. The signal was strongest and most consistent for P90, a metric defined as the 90th percentile of weekly PM2.5 concentrations measured across all monitoring stations nationwide. Unlike a simple weekly average, P90 captures how severe the worst exposures in a given week were, making it a sensitive indicator of pollution episodes. Crucially, the association at lags 5 and 6 remained statistically significant even when the anomalous year 2019 was removed from the analysis entirely, suggesting the pattern was not merely an artifact of a single dramatic event.

That event, however, remains the study’s most striking illustration. During epidemiological weeks 7 through 9 of 2019, South Korea experienced an exceptionally severe spring haze episode. Weekly mean PM2.5 concentrations averaged 53.3 micrograms per cubic meter during that stretch, with the 90th percentile reaching 70.1 micrograms per cubic meter — levels far above typical early-spring values and well beyond thresholds generally considered harmful. In the weeks that followed, influenza activity resurged, climbing to a peak at epidemiological weeks 15 and 16, a delay of roughly six to nine weeks from the pollution episode. The timing aligns closely with the five-to-six-week lags where the statistical association was strongest, providing a concrete case study for the broader pattern detected across the decade of data.

The researchers were careful to examine whether meteorology could explain away the connection. Cold, dry conditions are well established as favorable for influenza transmission, influencing both the survival of virus-laden aerosols and host susceptibility. In 2019, the weeks spanning the resurgence window — weeks 12 through 16 — recorded mean temperatures that ranked lowest among all study years and relative humidity that ranked second lowest, a combination that would independently favor viral spread. When the team adjusted for delayed meteorological effects in their models, the estimates at the later lags were attenuated, indicating that part of the apparent pollution-influenza association is entangled with the cold, dry weather that often accompanies severe spring haze episodes. The authors interpret this honestly: severe pollution episodes may not act alone, but rather in concert with transmission-friendly conditions that frequently follow them.

Additional lines of evidence strengthen the plausibility of a true viral phenomenon. The 2019 resurgence was clearly visible in pediatric influenza surveillance data, and importantly, no comparable increase appeared in surveillance of other respiratory viruses among hospitalized children. If the late-spring uptick had been driven by changes in testing behavior, healthcare-seeking patterns, or generic respiratory irritation from polluted air, one might expect other viruses to rise in parallel. Their absence points instead to influenza specifically. Laboratory work offers several biological mechanisms that could underlie a delayed effect: fine particles can impair antiviral immune defenses, suppress interferon responses and inflammasome activation in the airways, and reduce the antiviral activity of pulmonary macrophages through epigenetic changes, while also physically carrying viral particles deeper into the respiratory tract. Such pollution-induced immunological weakening could plausibly increase susceptibility to infection in the weeks following exposure, or facilitate chains of transmission among a population of partially immunocompromised hosts.

The findings carry practical implications for public health surveillance. If severe PM2.5 episodes during the late winter and spring can foreshadow influenza resurgences five or six weeks later, then real-time air quality data could serve as a supplementary environmental early-warning signal, prompting health authorities to intensify influenza monitoring, vaccination campaigns, and clinical preparedness in the weeks following a major haze event. The authors are careful to frame the association as conditional: the delayed link was evident during epidemiological weeks 8 through 20 rather than throughout the year, and the effect appeared to require the subsequent arrival of conditions favorable to transmission. In other words, a pollution episode may prime the population, but cold, dry weather appears to help light the fuse. With climate change and transboundary haze continuing to threaten air quality across East Asia, and with influenza seasons increasingly prone to unusual timing in the post-pandemic era, the ability to anticipate resurgence weeks in advance — even imperfectly — could prove a valuable addition to the epidemiologist’s toolkit. The study also underscores a broader lesson about the health consequences of air pollution: its harms may unfold not only in the hours and days after exposure, but across the weeks that follow.

Subject of Research: Delayed association between severe PM2.5 air pollution episodes and influenza resurgence in South Korea

Article Title: Delayed influenza resurgence following high PM2.5 episodes: insights from the 2019 spring anomaly in South Korea

Article References: Delayed influenza resurgence following high PM2.5 episodes: insights from the 2019 spring anomaly in South Korea. (n.d.). https://doi.org/10.1007/s11869-026-02096-0

Image Credits: AI Generated

DOI: 10.1007/s11869-026-02096-0

Keywords: PM2.5, influenza, air pollution, South Korea, distributed lag model, 2019 spring haze, epidemiology, respiratory virus, influenza surveillance, environmental health, seasonality, public health

The study, conducted by an Ethiopian-led consortium including the Armauer Hansen Research Institute and international collaborators from the Drugs for Neglected Diseases initiative and Spain’s Instituto de Salud Carlos III, was a multicenter, randomized, controlled, open-label, adaptive Phase II/III trial. It compared a single session of thermotherapy, in which a heated device delivers 50 degrees Celsius to the lesion for 30 seconds, against the current standard of weekly injections of pentavalent sodium stibogluconate directly into the lesion, a regimen that must continue for four to six weeks. Participants were adults aged 18 to 60 years with parasitologically confirmed, uncomplicated localized cutaneous leishmaniasis, enrolled across Ethiopian treatment sites including ALERT Comprehensive Specialized Hospital, Boru Meda General Hospital, and Wacha Health Center.

The trial was designed with methodological rigor unusual for studies in this field. Prespecified futility and interim analyses guided progression through the trial phases, and an independent Data and Safety Monitoring Board oversaw the process, ultimately recommending that the final phase II analysis include 183 participants. Of these, 91 were randomized to thermotherapy and 92 to intralesional sodium stibogluconate. Most participants were men, 60.4 percent in the thermotherapy arm and 53.3 percent in the drug arm, and the median age was 27 years. Cure was assessed at two time points: initial cure evaluated at day 90 or 105, and final cure assessed at day 180, using both intention-to-treat and per-protocol analyses to capture different views of treatment effect.

The intention-to-treat results, which include every participant as randomized, showed that initial cure rates were 44.0 percent for thermotherapy and 52.2 percent for intralesional sodium stibogluconate, a difference that did not reach statistical significance (p = 0.266). Final cure rates at day 180 were similarly comparable in this analysis, at 34.1 percent versus 43.5 percent (p = 0.191). By contrast, the per-protocol analysis, restricted to participants who completed treatment as assigned, found a statistically significant advantage for the drug regimen, with final cure rates of 39.2 percent for thermotherapy versus 57.6 percent for intralesional sodium stibogluconate (p = 0.032). This divergence between analytic perspectives reflects an important practical reality: some participants in the drug arm did not complete the full multi-week injection course, whereas thermotherapy required only a single visit.

The safety findings were unambiguous. No serious adverse events were reported in either arm, and all observed adverse events were mild and resolved without complications. Health-related quality of life, measured with validated dermatological instruments, improved significantly in both treatment arms after cure, indicating that successful lesion healing translates into tangible benefits in patients’ daily lives regardless of which therapy achieved it.

From a technical standpoint, the trial’s design choices deserve attention. The thermotherapy protocol, a single application of 50 degrees Celsius for 30 seconds, exploits the thermal sensitivity of Leishmania parasites within skin lesions, inducing local parasite killing while sparing surrounding tissue. Intralesional sodium stibogluconate, by contrast, relies on pentavalent antimonial compounds delivered directly into the lesion over repeated weekly visits. The adherence advantage observed for thermotherapy is therefore not a minor convenience but a structurally meaningful difference: a treatment requiring one healthcare visit is far easier to complete than one demanding four to six weekly presentations, particularly for patients in rural Ethiopia who may travel long distances and bear significant opportunity costs for each clinic visit.

The authors argue that in resource-limited Ethiopian settings, where most cutaneous leishmaniasis cases go entirely untreated and patients risk lifelong disfigurement, thermotherapy provides a pragmatic, single-session alternative wherever access to intralesional sodium stibogluconate is constrained. The intention-to-treat equivalence, combined with superior adherence and an acceptable safety profile, supports this position, even as the per-protocol results caution that patients who can reliably complete the full drug course may achieve somewhat higher cure rates with the standard therapy. The nuance matters for policy: the best treatment is not only the most efficacious in ideal conditions but the one patients can actually finish.

The study also fills a glaring evidence gap. Ethiopian clinical practice for L. aethiopica infections has historically been informed by trials conducted in other regions with different parasite species, most commonly Leishmania major or Leishmania tropica, whose responses to heat and antimonials can differ. By generating species-specific, locally grounded data, the trial gives Ethiopian clinicians and national program managers the kind of evidence needed to tailor treatment guidelines to the parasite actually circulating in their highland foci.

Funding for the work came in part from the European and Developing Countries Clinical Trials Partnership (EDCTP2) programme supported by the European Union, with the study device and medications supplied by the Drugs for Neglected Diseases initiative and molecular work supported by the Armauer Hansen Research Institute and Instituto de Salud Carlos III. The trial was registered in the Pan African Clinical Trials Registry (PACTR202205775486864) on 30 May 2022, and the article was published open access in BMC Medicine on 19 September 2026, ensuring that the results are freely available to the health systems that most need them.

For the global community working on neglected tropical diseases, the trial’s message is twofold. First, heat-based therapy can credibly compete with injectable drug regimens for localized cutaneous leishmaniasis when adherence to prolonged treatment is unrealistic, making it a candidate for scale-up in endemic districts. Second, the divergence between intention-to-treat and per-protocol outcomes is a reminder that in real-world neglected disease care, the route and duration of treatment are as decisive as the drug itself. As Ethiopia and neighboring endemic countries weigh how to expand care for a disease that has long hidden in plain sight, a thirty-second burst of controlled heat, delivered in a single visit, may prove to be one of the most pragmatic tools at their disposal.

Subject of Research: A phase II randomized controlled trial comparing thermotherapy with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous leishmaniasis in Ethiopia

Article Title: Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial

Article References: Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial. (n.d.). https://doi.org/10.1186/s12916-026-05244-6

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05244-6

Keywords: cutaneous leishmaniasis, Leishmania aethiopica, thermotherapy, intralesional sodium stibogluconate, randomized controlled trial, Ethiopia, treatment efficacy, neglected tropical diseases, phase II trial, adherence, BMC Medicine, public health

The research team set out to answer a question that has lingered at the margins of environmental health science for years. Animal experiments and cell studies have long indicated that lead can disrupt immune function, altering how immune cells respond to infection and how the respiratory tract handles invading bacteria and viruses. Epidemiological evidence in children, however, has been sparse and often limited to broad measures of general illness. By focusing specifically on clinically diagnosed infectious respiratory disease, conditions such as pneumonia, bronchitis, and other infections confirmed in medical settings, the new study provides one of the clearest pictures yet of how environmental lead exposure relates to real, documented illness in childhood.

The study population consisted of urban and disadvantaged children, a group chosen deliberately. Children in these settings face a constellation of overlapping risks: aging housing stock with deteriorating lead paint and lead-contaminated dust, proximity to traffic and industry, limited access to preventive healthcare, higher rates of crowding, and nutritional deficiencies that can themselves impair immunity. Disentangling the contribution of lead from this tangle of factors is one of the central methodological challenges of environmental epidemiology, and the researchers approached it with a battery of statistical adjustments designed to isolate the exposure of interest.

Technically, the investigators assessed lead exposure using biomarkers that reflect the body’s cumulative burden of the metal. Blood lead levels, the most common clinical measure, capture relatively recent exposure over the preceding weeks to months. Where available, the study also drew on measures that integrate exposure over longer periods, such as dentine lead levels in shed baby teeth, which record the lead a child absorbed during early development much as tree rings record growing conditions. Combining these biomarkers allowed the team to examine both contemporaneous and historical exposure, an important distinction because the immune consequences of lead may depend on when during development the exposure occurs.

Clinical infectious respiratory disease was identified through medical diagnoses rather than parental reports of symptoms, a design choice that reduces recall bias and anchors the outcome in verified healthcare encounters. The researchers then modeled the relationship between lead biomarkers and disease occurrence while accounting for a range of potential confounders, including household socioeconomic status, parental education, exposure to tobacco smoke, housing conditions, and other environmental co-exposures. The analytic strategy reflects a growing consensus in exposure science that single-pollutant models can be misleading in disadvantaged communities, where children are rarely exposed to one hazard at a time.

The results indicated that children with higher lead burdens experienced more clinically diagnosed infectious respiratory disease than their peers with lower exposures. While the observational design of the study cannot prove that lead caused the infections, the association persisted after adjustment for major confounding factors, and it aligns with a coherent biological story. Lead is known to interfere with several arms of the immune system. It can impair the function of macrophages, the scavenger cells that engulf bacteria and debris in the lung; it can alter the balance of T helper cell responses, shifting immunity away from patterns that effectively combat certain pathogens; and it can disrupt the production of antibodies and the integrity of epithelial barriers that line the airways. Any of these mechanisms, alone or in combination, could plausibly translate into increased susceptibility to respiratory infection.

The findings carry particular weight for immunology because they connect a ubiquitous environmental toxicant to a clinically meaningful outcome through mechanisms that laboratory science has already sketched out. In experimental systems, lead-exposed animals show diminished resistance to bacterial pneumonia and altered cytokine responses to viral challenge. Human studies have linked lead exposure with changes in circulating immune cell populations and reduced vaccine antibody titers in some contexts. The new study extends this evidence into the realm of everyday pediatric illness, suggesting that the immunological fingerprints observed in the laboratory may manifest as pneumonia and bronchitis diagnoses in children’s medical records.

For public health, the implications are sobering. Lead exposure remains far from a solved problem in many cities. Flint, Michigan, made headlines as an extreme case, but thousands of communities across the United States and around the world continue to grapple with lead in drinking water, soil, paint, and dust. Children in disadvantaged neighborhoods absorb disproportionately high exposures precisely because of the legacy of discriminatory housing and industrial siting policies. If lead additionally raises the risk of respiratory infections, then the true cost of these exposures extends beyond neurodevelopmental harm into the domain of infectious disease, a burden that falls on families, healthcare systems, and schools.

The study also arrives at a moment when respiratory infections have assumed renewed prominence in public consciousness. The COVID-19 pandemic demonstrated how sharply infectious respiratory disease can shape societies, and it highlighted the importance of understanding why some individuals, and some communities, suffer more severe outcomes than others. Environmental exposures such as air pollution have been implicated in worse COVID-19 outcomes, and the new lead findings fit into a broader picture in which the environments children inhabit quietly program the resilience of their immune systems. A child’s ability to fight off pneumonia may depend not only on nutrition, vaccination, and access to care, but also on the toxic legacy embedded in the dust on their windowsills.

Several questions remain open. The observational nature of the study means residual confounding cannot be excluded; unmeasured differences between more and less exposed children, such as healthcare access or viral exposure intensity, may contribute to the association. The dose-response relationship, the critical question of how much lead is needed to meaningfully alter infection risk, requires further quantification, particularly at the lower exposures now common in many countries. And the biological pathways in humans, rather than in animal models, remain to be fully characterized. Longitudinal birth cohorts that follow children from pregnancy through childhood, collecting repeated biomarkers and clinical outcomes, would be the natural next step.

Even so, the study strengthens the case for aggressive lead abatement as a respiratory health intervention, not merely a neurodevelopmental one. Replacing lead service lines, remediating lead paint in older housing, cleaning contaminated soils, and enforcing housing codes are interventions with well-established benefits for cognitive development. If they also reduce the incidence of childhood pneumonia and bronchitis, the health-economic calculus shifts further in favor of action. Every dollar spent removing lead from a child’s environment may return dividends not only in test scores and behavior, but in fewer nights in the emergency department, fewer courses of antibiotics, and fewer disrupted school years. In a sample of urban and disadvantaged children, the study reminds us that the environment they breathe and touch is inseparable from the immune defenses they carry within.

Subject of Research: The association between environmental lead exposure and clinically diagnosed infectious respiratory disease in urban and disadvantaged children.

Article Title: Environmental lead exposure and clinical infectious respiratory disease in a sample of urban and disadvantaged children

Article References: Odiko, E., Stutz, R., Nie, J., Lehman, H. K., Turella, J., Khan, A. I., & Feiler, M. O. (2026). Environmental lead exposure and clinical infectious respiratory disease in a sample of urban and disadvantaged children. Journal of Exposure Science & Environmental Epidemiology. https://doi.org/10.1038/s41370-026-00978-0

Image Credits: AI Generated

DOI: 10.1038/s41370-026-00978-0

Keywords: lead exposure, children's health, respiratory infection, environmental epidemiology, immunotoxicology, urban health, health disparities, blood lead levels, pneumonia, public health, toxicology, immune system